Christine Kline, the Senior Vice President and CAO of $UTI, sold 3,500 shares of the company on 06-05-2026 for an estimated $155,476. We received data on the trade from a recent SEC filing. This was a sale of approximately 7.5% of their shares of this class of stock. Following this trade, they now own 43,006 shares of this class of $UTI stock.
$UTI Insider Trading Activity
$UTI insiders have traded $UTI stock on the open market 10 times in the past 6 months. Of those trades, 0 have been purchases and 10 have been sales.
Here’s a breakdown of recent trading of $UTI stock by insiders over the last 6 months:
- JEROME ALAN GRANT (Chief Executive Officer) sold 60,040 shares for an estimated $2,098,494
- SHERRELL SMITH (EVP, Chief Academic Officer) has made 0 purchases and 2 sales selling 52,671 shares for an estimated $1,951,021.
- CHRISTOPHER E. KEVANE (EVP and Chief Legal Officer) sold 23,654 shares for an estimated $888,115
- TODD A HITCHCOCK (EVP/COO) sold 16,500 shares for an estimated $615,945
- LINDA J SRERE sold 15,000 shares for an estimated $548,800
- SHANNON LEI OKINAKA sold 10,000 shares for an estimated $347,414
- GEORGE W. BROCHICK sold 5,000 shares for an estimated $182,938
- CHRISTINE KLINE (Senior Vice President and CAO) sold 3,500 shares for an estimated $155,476
- CAROLYN ANN FRANK (SVP/Chief HR Officer) sold 1,750 shares for an estimated $52,634
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
$UTI Hedge Fund Activity
We have seen 133 institutional investors add shares of $UTI stock to their portfolio, and 157 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- DRIEHAUS CAPITAL MANAGEMENT LLC added 1,387,525 shares (+376.0%) to their portfolio in Q1 2026, for an estimated $50,089,652
- MACQUARIE GROUP LTD removed 1,265,713 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $33,073,080
- CONESTOGA CAPITAL ADVISORS, LLC added 1,203,985 shares (+1366.0%) to their portfolio in Q1 2026, for an estimated $43,463,858
- PRAETORIAN PR LLC added 1,000,000 shares (+inf%) to their portfolio in Q1 2026, for an estimated $36,100,000
- POINT72 ASSET MANAGEMENT, L.P. added 466,413 shares (+47.7%) to their portfolio in Q1 2026, for an estimated $16,837,509
- CONGRESS ASSET MANAGEMENT CO added 458,805 shares (+27.1%) to their portfolio in Q1 2026, for an estimated $16,562,860
- VICTORY CAPITAL MANAGEMENT INC removed 362,395 shares (-84.4%) from their portfolio in Q4 2025, for an estimated $9,469,381
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
$UTI Revenue
$UTI had revenues of $221.4M in Q2 2026. This is an increase of 6.73% from the same period in the prior year.
You can track UTI financials on Quiver Quantitative's UTI stock page.
You can access data on UTI stock through the Quiver Quantitative API.
$UTI Analyst Ratings
Wall Street analysts have issued reports on $UTI in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Barrington Research issued a "Outperform" rating on 01/21/2026
To track analyst ratings and price targets for $UTI, check out Quiver Quantitative's $UTI forecast page.
$UTI Price Targets
Multiple analysts have issued price targets for $UTI recently. We have seen 2 analysts offer price targets for $UTI in the last 6 months, with a median target of $43.5.
Here are some recent targets:
- Alexander Paris from Barrington Research set a target price of $42.0 on 05/07/2026
- Steve Frankel from Rosenblatt set a target price of $45.0 on 05/07/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
